Bone mineral density in systemic lupus erythematosus: Comparison with rheumatoid arthritis and healthy controls

Annals of the Rheumatic Diseases

Volumn 59, Issue 2, 2000, Pages 110-115

  Gilboe, Inge Margrethe ^a   Kvien, Tore K ^a   Haugeberg, Glenn ^a   Husby, Gunnar ^b  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PREMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BONE DENSITY; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; PREMENOPAUSE; RISK FACTORS;

EID: 0034030376     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.2.110     Document Type: Article

References (38)

1. 1 Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
2. 2 Anonymous. Consensus Development Conference: Prophylaxis and treatment of Osteoporosis. Osteoporosis Int 1991;114-17.
3. 3 Pons F, Peris P, Guanabens N, Font J, Huguet M, Espinosa G, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
4. 4 Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer J-P, Nagant de Deuxchaines C, Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996;35:244-7.
5. 5 Li EK, Tam LS, Young RP, Ko GTC, Li M, Lau EMC. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 1998;37:405-10.
6. 6 Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus. J Rheumatol 1997; 24: 1922-9.
7. 7 Kalla AA, Fataar AB, Jessop S, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
8. 8 Dhillon VB, Davies M, Hall ML, Round J, Ell PJ, Jacobs HS, et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: A preliminar study with dual enery x-ray absorptiometry. Ann Rheum Dis 1990;49:624-6.
9. 9 Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
10. 10 Hansen M, Halberg P, Kollerup G, Pedersen-Zbinden B, Horslev-Petersen K, Hyldstrup I., et al. Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glycocorticoid treatment. Scand J Rheumatol 1998;27:197-206.
11. 11 Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, Morand E. Three years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 1999;26:310-17.
12. 12 Dykman TR, Gluck OS, Murphy W, Hahn T, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-8.
13. 13 Kalla AA, Meyers OL, Parkyn N, Kotze T. Osteoporosis screening-radiogrammetry revisited. Br J Rheumatol 1989; 28:511-17.
14. 14 Kalla AA, Meyers OL, Kotze T, Laubesher R. Corticosteroid therapy and bone mass - comparison of rheumatoid arthritis and systemic lupus erythematosus. S Afr Med J 1994;84:404-9.
15. 15 Kvien TK, Glennås A, Knudsrød OG, Smedstad LM, Mowinkel P, Førre Ø. The prevalence and severity of rheumatoid arthritis in Oslo: Result form a county register and a population survey. Scand J Rheumatol 1997;26:412-18.
16. 16 Uhlig T, Kvien TK, Glennås A, Smedstad LM, Førre Ø. The incidence and severity of rheumatoid arthritis. Results from a county register in Oslo, Norway. J Rheumatol 1998; 25:1078-84.
17. 17 Tan EM, Cohen AS, Fries JF, Alfonse TM, McShane DJ, Rothefield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. 18 Arnett FC, Edworthy SM, Bloch AB, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid artritis. Arthritis Rheum 1988;31:315-24.
19. 19 Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum 1983;26:46-53.
20. 20 Ware JE, Sherbourne CD. The MOS 36-item Short Form health Survey (SF-36) I. Conceptual framework and item selection. Med Care 1992;30:473-83.
21. 21 Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23: 37-45.
22. 22 Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the committee on prognosis studies in SLE. Derivation of SLEDAI. Arthritis Rheum 1992;35: 30-40.
23. 23 Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
24. 24 Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: A review. Br J Rheumatol 1996;35:309-22.
25. 25 Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993;36:1510-16.
26. 26 Martin JC, Munro R, Campbell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 1997;36: 43-9.
27. 27 Gilboe IM, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999;26:1694-700.
28. 28 Segal LG, Lane NE. Osteoporosis and systemic lupus erythematosus: etiology and treatment strategies. Ann Med Interne (Paris) 1996;147:281-9.
29. 29 McLeod JF. Osteoporosis, cytokines, and glucocorticoids. Allergy Proc 1993;14:363-4.
30. 30 Tanaka Y, Watanabe K, Suzuki M, Saito K, Oda S, Suzuki H, et al. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol 1989;9:415-20.
31. 31 Seitz M, Hunstein W. Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. Ann Rheum Dis 1985;44: 438-45.
32. 32 Maury C, Teppo A-M. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:146-50.
33. 33 Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54:801-6.
34. 34 Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: An update. Arthritis Care Res 1995;8:37-45.
35. 35 Ramsey-Goldman R, Dunn J, Huang C-F, Dunlop D, Rairie J, Fritzgerald S, et al. Frequency of fractures in women with systemic lupus erythematosus. Arthritis Rheum 1999;42: 882-90.
36. 36 Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991;114:919-23.
37. 37 Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993;341:72-5.
38. 38 Sambrook PN, Jones G. Corticosteroid osteoporosis. Br J Rheumatol 1995;34:8-12.